Fairvalue-Calculator Fairvalue-Calculator
EN DE

Jeil Pharmaceutical Co (271980) Fair Value & Analysis

Healthcare · KR · Market cap 149B KRW

Price9,550 KRW
Fair Value15,977 KRW
Upside+67.3%
Quality83/100
Evidence: Medium Range 14,344 KRW – 21,777 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Jeil Pharmaceutical Co (271980) currently trades at 9,550 KRW, while our model-based Fair Value estimate is 15,977 KRW — implying the stock looks roughly 67.3% undervalued today. We read business quality at 83/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea and internationally. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company exports its products. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Jeil Pharmaceutical Co (271980) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 15,977 KRW versus a price of 9,550 KRW — about +67% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 271980?
Our 21-model fair value for Jeil Pharmaceutical Co is 15,977 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 9,550 KRW.
What is the quality score of 271980?
Jeil Pharmaceutical Co has a Quality Score of 83/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.